CellSpring develops minimally invasive tests to diagnose early stage cancer. Our 3D Bloom technology effectively tricks cancer cells into revealing the molecular signature of Extracellular Vesicles (EVs) they secrete. Diagnostic test kits under development will isolate and quantify cancer EVs that might be present in a patient's blood.
Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available.
At CellSpring, we are highly grateful for all the support received from our partners.
